Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Zalcitabine or its saltsPDL I DEC / 13
Zaleplon or its salts or its derivativesPDL I NOV / 18
Zanamivir or its salts or derivativesPDL I DEC / 13
ZeranolC3 I SEP / 98
ZidovudinePDL I DEC / 13
Zinc chloride in injectable form for parenteral nutrition I JAN / 03
Zinc sulfate in injectable form for parenteral nutrition I JAN / 03
Ziprasidone or its saltsPDL I DEC / 13
Zoledronic acid or its salts or derivativesPDL I DEC / 13
Zolmitriptan or its saltsPDL I DEC / 13
Zolpidem and any salts thereofTS I JAN / 03
Zomepirac or its saltsPDL I DEC / 13
Zopiclone or its saltsPDL I DEC / 13
ZucapsaicinPDL I DEC / 13
Zuclopenthixol or its salts or derivativesPDL

Including but not limited to zuclopenthixol decanoate, zuclopenthixol hydrochloride.

I DEC / 13
a - MethylthiofentanylN I JUN / 02
alpha1- proteinase inhibitor (human) I JAN / 06
p-FluorofentanylN I JUN / 02

2018 result(s)


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act